Sciensus leadership update

Christian Tucat has stepped down as CEO and Board Member of Sciensus Pharma Services Limited and as a Board Member of Halcyon Topco Limited.

The Board has appointed Gordon Cox as Interim CEO. Gordon has served as Chief Operating Officer of Sciensus since 2021 and brings strong operational leadership and continuity to the role.

Sciensus has successfully digitised patient interactions in recent years and built strong capabilities across Chronic and Cancer Care, as well as Rare and Specialty Disease GTM partnerships. The business will continue to execute its strategy and deliver the highest level of service and support to patients, customers and partners.